Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

Abstract Aims Little is known about the long‐term outcomes of β‐blockers use in patients with coronary artery disease (CAD) without myocardial infarction (MI) and reduced ejection fraction (rEF). However, more attention should be paid to the oral administration of β‐blockers in elderly patients who...

Full description

Bibliographic Details
Main Authors: Tatsuya Fukase, Tomotaka Dohi, Takuma Koike, Hidetoshi Yasuda, Mitsuhiro Takeuchi, Norihito Takahashi, Yuichi Chikata, Hirohisa Endo, Shinichiro Doi, Hiroki Nishiyama, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, Katsumi Miyauchi, Hiroyuki Daida, Tohru Minamino
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:ESC Heart Failure
Subjects:
β‐Blockers
Heart failure
Coronary artery disease
Percutaneous coronary intervention
Long term
Online Access:https://doi.org/10.1002/ehf2.13715

Internet

https://doi.org/10.1002/ehf2.13715

Similar Items